Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|May 31, 2021
Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potentialAriana A Entezari, Adam E Snook, Scott A Waldman
Personalized Medicine|August 3, 2022
Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancerAdi Caspi, Ariana A Entezari, Madison Crutcher, et al.
Frontiers in Neuroscience|November 29, 2023
Enteroendocrine cell regulation of the gut-brain axisJoshua R Barton, Annie K Londregan, Tyler D Alexander, et al.
Cancer Biology & Therapy|July 26, 2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancerAllison S Doermann, Adi Caspi, Andrew E Evans, et al.
Cancer Biology & Therapy|June 30, 2020
Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosityAmanda M Pattison, Joshua R Barton, Ariana A Entezari, et al.
Cancer Biology & Therapy|September 24, 2024
CD8α Structural Domains Enhance GUCY2C CAR-T Cell EfficacyTrevor R Baybutt, Ariana A Entezari, Adi Caspi, et al.
The Journal of Clinical Investigation|December 22, 2022
Intestinal neuropod cell GUCY2C regulates visceral painJoshua R Barton, Annie K Londregan, Tyler D Alexander, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2021
A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal CancerJeffrey A Rappaport, Ariana A Entezari, Adi Caspi, et al.
Pageof 1